The 68-year-old client with type 2 diabetes and stage 3 chronic kidney disease, admitted for pneumonia that is improving on room air, ate 25% of dinner. Capillary glucose was 102 mg/dL at 1600 and 78 mg/dL at 2030. The client is alert, oriented, and denies palpitations or sweating. The 2100 medication administration record lists 2 active orders: insulin degludec 24 units subcutaneously and insulin glargine 20 units subcutaneously. The client reports using degludec 24 units at bedtime at home and has never used 2 long-acting insulins together. There is no order for correction insulin at bedtime. Blood pressure is 126/72 mm Hg. Complete the diagram by selecting the problem the client is most likely experiencing, 2 actions the nurse should take to address that problem, and 2 parameters the nurse should monitor to assess the client's progress.

Quick answer
Unintended duplicate basal insulin orders. Actions: hold both basal insulin doses until clarified; contact the prescriber and pharmacist to reconcile. Monitor: capillary blood glucose, and tremor, sweating, and confusion.

Why this is correct
Degludec and glargine are both basal insulins; having both active is a therapeutic duplication. The client's home regimen confirms only one was intended. The nurse cannot choose which order is correct, because the dose may need reduction for reduced intake and CKD, which slows insulin clearance. Closed-loop reconciliation with the prescriber and pharmacist resolves the error before any dose is given.

Easy analogy or mental picture
Two pilots grabbing the same steering wheel: before the plane moves, the tower (prescriber and pharmacist) must decide who flies, and the nurse keeps both hands off until then.

Memory hook
Two basals = zero until clarified.

NCLEX decision rule
When a high-alert medication order is duplicated or unclear, withhold it and clarify with the prescriber; do not resolve the discrepancy by choosing a dose on your own or by asking the client to choose.

Why the other choices are wrong
An intended split regimen would use one basal product twice, not 2 different basal products the client never used together. A formulary substitution would replace one order, not leave both active. Glucose 78 mg/dL is not yet hypoglycemia (below 70 mg/dL) and the client is asymptomatic, so 15 g of carbohydrate treats a problem that has not occurred and ignores the order error. Giving only degludec or only glargine is tempting but is an independent prescribing decision. Urine ketones, A1c, and creatinine do not track the overnight hypoglycemia risk.